Maravai LifeSciences Holdings, Inc. (MRVI) vs Viridian Therapeutics, Inc. (VRDN)
A side-by-side comparison of Maravai LifeSciences Holdings, Inc. and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRVI
Maravai LifeSciences Holdings, Inc.
$7.85HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VRDN
Viridian Therapeutics, Inc.
$18.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRVI vs VRDN
growth of $100 · dividends reinvested · last 6yMRVI -71.5% (-18.9%/yr)VRDN +10.2% (+1.6%/yr)VRDN compounded faster over this window
MRVI VRDN
MRVI vs VRDN: by the numbers
- •MRVI is the larger company ($2.17B vs $2.06B market cap).
- •Both run net losses; MRVI's is the smaller (-37.07% vs -544.06% net margin).
- •VRDN grew revenue faster over the past five years (93.92% vs -17.68% CAGR).
Metrics side by side
Valuation
| Metric | MRVI | VRDN |
|---|---|---|
| P/S ratio | 10.39 | 29.02 |
| P/B ratio | 10.60 | 3.66 |
| EV / EBITDA | 15.02 | N/A |
Profitability
| Metric | MRVI | VRDN |
|---|---|---|
| Gross margin | 17.98% | 99.55% |
| Operating margin | -3.63% | -512.91% |
| Net margin | -37.07% | -544.06% |
| ROE | -37.82% | -58.45% |
| ROIC | 16.96% | -39.18% |
Growth (annualized)
| Metric | MRVI | VRDN |
|---|---|---|
| Revenue CAGR (5Y) | -17.68% | 93.92% |
| Total return CAGR (5Y) | -27.63% | 1.64% |
Frequently asked
- Which has grown faster, MRVI or VRDN?
- Over the past five years, VRDN grew revenue faster — MRVI at a -17.68% CAGR versus VRDN at 93.92%.
- How have MRVI and VRDN total returns compared?
- Over the past 5 years, MRVI delivered -27.63% and VRDN delivered 1.64% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Maravai LifeSciences ROEViridian Therapeutics ROEMaravai LifeSciences operating marginViridian Therapeutics operating marginMaravai LifeSciences revenue growthViridian Therapeutics revenue growthMaravai LifeSciences free cash flowViridian Therapeutics free cash flow
Maravai LifeSciences & Viridian Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.